292 related articles for article (PubMed ID: 17079316)
1. Small interfering RNA targeted to hepatitis C virus 5' nontranslated region exerts potent antiviral effect.
Kanda T; Steele R; Ray R; Ray RB
J Virol; 2007 Jan; 81(2):669-76. PubMed ID: 17079316
[TBL] [Abstract][Full Text] [Related]
2. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.
Krönke J; Kittler R; Buchholz F; Windisch MP; Pietschmann T; Bartenschlager R; Frese M
J Virol; 2004 Apr; 78(7):3436-46. PubMed ID: 15016866
[TBL] [Abstract][Full Text] [Related]
3. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
Jarczak D; Korf M; Beger C; Manns MP; Krüger M
FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
[TBL] [Abstract][Full Text] [Related]
4. Small interfering RNA targeted to stem-loop II of the 5' untranslated region effectively inhibits expression of six HCV genotypes.
Prabhu R; Garry RF; Dash S
Virol J; 2006 Nov; 3():100. PubMed ID: 17129382
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of IRES containing 5'UTR of HCV genotype 3a using siRNAs.
Khaliq S; Jahan S; Pervaiz A; Ali Ashfaq U; Hassan S
Virol J; 2011 May; 8():221. PubMed ID: 21569449
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.
Gottwein JM; Scheel TK; Jensen TB; Lademann JB; Prentoe JC; Knudsen ML; Hoegh AM; Bukh J
Hepatology; 2009 Feb; 49(2):364-77. PubMed ID: 19148942
[TBL] [Abstract][Full Text] [Related]
7. Multiple effects of Honokiol on the life cycle of hepatitis C virus.
Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD
Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176
[TBL] [Abstract][Full Text] [Related]
8. shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA.
Vlassov AV; Korba B; Farrar K; Mukerjee S; Seyhan AA; Ilves H; Kaspar RL; Leake D; Kazakov SA; Johnston BH
Oligonucleotides; 2007; 17(2):223-36. PubMed ID: 17638526
[TBL] [Abstract][Full Text] [Related]
9. Cell type-specific enhancement of hepatitis C virus internal ribosome entry site-directed translation due to 5' nontranslated region substitutions selected during passage of virus in lymphoblastoid cells.
Lerat H; Shimizu YK; Lemon SM
J Virol; 2000 Aug; 74(15):7024-31. PubMed ID: 10888641
[TBL] [Abstract][Full Text] [Related]
10. TAT peptides mediated small interfering RNA delivery to Huh-7 cells and efficiently inhibited hepatitis C virus RNA replication.
Meng S; Wei B; Xu R; Zhang K; Wang L; Zhang R; Li J
Intervirology; 2009; 52(3):135-40. PubMed ID: 19478527
[TBL] [Abstract][Full Text] [Related]
11. Role of the 5'-proximal stem-loop structure of the 5' untranslated region in replication and translation of hepatitis C virus RNA.
Luo G; Xin S; Cai Z
J Virol; 2003 Mar; 77(5):3312-8. PubMed ID: 12584356
[TBL] [Abstract][Full Text] [Related]
12. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
[TBL] [Abstract][Full Text] [Related]
13. Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication.
Roy S; Gupta N; Subramanian N; Mondal T; Banerjea AC; Das S
J Gen Virol; 2008 Jul; 89(Pt 7):1579-1586. PubMed ID: 18559927
[TBL] [Abstract][Full Text] [Related]
14. Sequences in the 5' nontranslated region of hepatitis C virus required for RNA replication.
Friebe P; Lohmann V; Krieger N; Bartenschlager R
J Virol; 2001 Dec; 75(24):12047-57. PubMed ID: 11711595
[TBL] [Abstract][Full Text] [Related]
15. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the hepatitis C virus genome replication by miR-199a.
Murakami Y; Aly HH; Tajima A; Inoue I; Shimotohno K
J Hepatol; 2009 Mar; 50(3):453-60. PubMed ID: 19144437
[TBL] [Abstract][Full Text] [Related]
17. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
[TBL] [Abstract][Full Text] [Related]
18. Natural variation in translational activities of the 5' nontranslated RNAs of hepatitis C virus genotypes 1a and 1b: evidence for a long-range RNA-RNA interaction outside of the internal ribosomal entry site.
Honda M; Rijnbrand R; Abell G; Kim D; Lemon SM
J Virol; 1999 Jun; 73(6):4941-51. PubMed ID: 10233956
[TBL] [Abstract][Full Text] [Related]
19. Short hairpin-looped oligodeoxynucleotides reduce hepatitis C virus replication.
Broecker F; Moelling K
Virol J; 2012 Jul; 9():134. PubMed ID: 22823899
[TBL] [Abstract][Full Text] [Related]
20. Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome.
Takigawa Y; Nagano-Fujii M; Deng L; Hidajat R; Tanaka M; Mizuta H; Hotta H
Microbiol Immunol; 2004; 48(8):591-8. PubMed ID: 15322339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
